[go: up one dir, main page]

FR2447725A3 - INHALER OF POWDERY DRUG SUBSTANCES, COMBINING THE FUNCTION OF DOSER - Google Patents

INHALER OF POWDERY DRUG SUBSTANCES, COMBINING THE FUNCTION OF DOSER

Info

Publication number
FR2447725A3
FR2447725A3 FR8002322A FR8002322A FR2447725A3 FR 2447725 A3 FR2447725 A3 FR 2447725A3 FR 8002322 A FR8002322 A FR 8002322A FR 8002322 A FR8002322 A FR 8002322A FR 2447725 A3 FR2447725 A3 FR 2447725A3
Authority
FR
France
Prior art keywords
function
cavity
inhalation
chamber
doser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8002322A
Other languages
French (fr)
Other versions
FR2447725B3 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2447725A3 publication Critical patent/FR2447725A3/en
Application granted granted Critical
Publication of FR2447725B3 publication Critical patent/FR2447725B3/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Nozzles (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

L'INHALATEUR POUR LA PRISE PAR INHALATION DE SUBSTANCES MEDICAMENTEUSES PULVERULENTES, QUI REMPLIT EN MEME TEMPS LA FONCTION DE DOSEUR, COMPREND: UNE TUBULURE D'INHALATION 1, UNE CHAMBRE DESTINEE A CONTENIR LADITE SUBSTANCE MEDICAMENTEUSE ET SUSCEPTIBLE DE TOURNER PAR RAPPORT A LADITE TUBULURE, ET UNE CAVITE 18 DESTINEE A RECEVOIR DES DOSES SUCCESSIVES DE LA SUBSTANCE MEDICAMENTEUSE, CETTE CAVITE ETANT EN COMMUNICATION AVEC LADITE TUBULURE. DES MOYENS DOSEURS 14, 14, 15 MENAGES SUR LE FOND 10 DE LA CHAMBRE 8, COOPERENT AVEC DES MOYENS DISTRIBUTEURS 16, 17 ACTIONNES PAR LA ROTATION RELATIVE ENTRE LA CHAMBRE 8 ET LA TUBULURE 1, POUR FAIRE TOMBER DANS LA CAVITE 18, DES DOSES INDIVIDUELLES SUCCESSIVES DE SUBSTANCE MEDICAMENTEUSE, QUI PEUVENT ETRE PRISES PAR INHALATION A TRAVERS LADITE TUBULURE.THE INHALATOR FOR THE TAKING BY INHALATION OF PULVERULENT MEDICINAL SUBSTANCES, WHICH AT THE SAME TIME PERFORMS THE FUNCTION OF A DOSING UNIT, INCLUDES: AN INHALATION TUBING 1, A CHAMBER DESIGNED TO CONTAIN THE SUCH DRUG SUBSTANCE AND SUSCEPTIBLE SUSCEPTIBLE SUSCEPTIBLE REPORT AND A CAVITY 18 INTENDED TO RECEIVE SUCCESSIVE DOSES OF THE MEDICINAL SUBSTANCE, THIS CAVITY BEING IN COMMUNICATION WITH THE SAID TUBING. MEANS OF DOSING 14, 14, 15 HOUSEHOLDS ON BOTTOM 10 OF CHAMBER 8, COOPERATE WITH MEANS OF DISTRIBUTORS 16, 17 ACTIVATED BY THE RELATIVE ROTATION BETWEEN CHAMBER 8 AND TUBULURE 1, TO DROP INTO CAVITY 18, DOSES SUCCESSIVE INDIVIDUALS OF A DRUG SUBSTANCE, WHICH CAN BE TAKEN BY INHALATION THROUGH THE SAID TUBULURE.

FR8002322A 1979-02-05 1980-01-30 INHALER OF POWDERY DRUG SUBSTANCES, COMBINING THE FUNCTION OF DOSER Granted FR2447725A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI1979U20688U IT7920688U1 (en) 1979-02-05 1979-02-05 Inhaler for powdered medicinal substances, with combined dosing function

Publications (2)

Publication Number Publication Date
FR2447725A3 true FR2447725A3 (en) 1980-08-29
FR2447725B3 FR2447725B3 (en) 1981-01-02

Family

ID=11170583

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8002322A Granted FR2447725A3 (en) 1979-02-05 1980-01-30 INHALER OF POWDERY DRUG SUBSTANCES, COMBINING THE FUNCTION OF DOSER

Country Status (5)

Country Link
DE (1) DE8002702U1 (en)
ES (1) ES248348Y (en)
FR (1) FR2447725A3 (en)
GB (1) GB2041763B (en)
IT (1) IT7920688U1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524769A (en) * 1981-07-08 1985-06-25 Aktiebolaget Draco Dosage inhalator
EP0520440A1 (en) * 1991-06-26 1992-12-30 Schering Corporation Inhalation device for powdered medicaments
EP0547429A1 (en) * 1991-12-14 1993-06-23 ASTA Medica Aktiengesellschaft Powder inhaler
WO2003000325A1 (en) 2001-06-22 2003-01-03 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE438261B (en) * 1981-07-08 1985-04-15 Draco Ab USE IN A DOSHALATOR OF A PERFORED MEMBRANE
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FI69963C (en) * 1984-10-04 1986-09-12 Orion Yhtymae Oy DOSERINGSANORDNING
US5046493A (en) * 1988-02-16 1991-09-10 James Kropkowski Nasal dispenser
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
DE4004904A1 (en) * 1990-02-16 1990-09-13 Gerhard Brendel DRUM APPLICATOR
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
YU48707B (en) 1990-03-02 1999-07-28 Glaxo Group Limited Inhalation device
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SK280967B6 (en) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalation device
US5615670A (en) * 1990-03-07 1997-04-01 Fisons Plc Powder inhaler with centrifugal force used to meter powder
GB9005110D0 (en) * 1990-03-07 1990-05-02 Fisons Plc Inhalation device
IT1240750B (en) * 1990-04-12 1993-12-17 Chiesi Farma Spa DEVICE FOR THE ADMINISTRATION OF MEDICAMENTOUS POWDER SUBSTANCES
GB9015522D0 (en) * 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
FR2667509B1 (en) * 1990-10-04 1995-08-25 Valois POWDER INHALER, DEVICE FOR PACKAGING POWDER MICRODOSES IN THE FORM OF BANDS SUITABLE FOR USE IN A POWDER INHALER, AND METHOD FOR MANUFACTURING SUCH BANDS.
US5243970A (en) * 1991-04-15 1993-09-14 Schering Corporation Dosing device for administering metered amounts of powdered medicaments to patients
IT1248059B (en) * 1991-06-14 1995-01-05 Miat Spa MULTI-DOSE INSUFFLATOR FOR POWDER DRUGS
GB9123953D0 (en) * 1991-11-12 1992-01-02 Minnesota Mining & Mfg Inhalation device
US5469843A (en) * 1991-11-12 1995-11-28 Minnesota Mining And Manufacturing Company Inhalation device
SE9201411D0 (en) * 1992-05-05 1992-05-05 Astra Ab DOSAGE INHALATOR WITH INDICATING / INTERUPTING MEANS
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
EP0674533B1 (en) * 1992-12-18 1999-03-10 Schering Corporation Inhaler for powdered medications
US5441060A (en) * 1993-02-08 1995-08-15 Duke University Dry powder delivery system
EP0692990B1 (en) * 1993-04-06 1998-09-23 Minnesota Mining And Manufacturing Company Deagglomerators for dry powder inhalers
US5533502A (en) * 1993-05-28 1996-07-09 Vortran Medical Technology, Inc. Powder inhaler with aerosolization occurring within each individual powder receptacle
GB9326574D0 (en) * 1993-12-31 1994-03-02 King S College London Dry power inhalers
DE4415462C1 (en) * 1994-05-03 1995-08-31 Transcoject Marketing Gmbh Inhaler for powdered medicine etc.
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
EP1862164A3 (en) * 1998-11-13 2012-12-26 Jagotec AG Dry powder for inhalation
JP4540906B2 (en) 1999-06-05 2010-09-08 イノバータ・バイオメッド・リミテッド Extrusion system
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
NZ521034A (en) 2000-02-28 2004-08-27 Vectura Ltd Improvements in or relating to the delivery of oral drugs
KR100527649B1 (en) * 2000-06-12 2005-11-09 데이진 가부시키가이샤 Powder medicine multiple dose administration device
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
EP1488819A1 (en) 2003-06-16 2004-12-22 Rijksuniversiteit te Groningen Dry powder inhaler and method for pulmonary inhalation of dry powder
CA2562386C (en) 2004-04-21 2014-11-18 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
PT1905451E (en) 2004-05-31 2010-03-31 Almirall Sa Combinations comprising antimuscarinic agents and corticosteroids
ES2257152B1 (en) 2004-05-31 2007-07-01 Laboratorios Almirall S.A. COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS.
ES2265276B1 (en) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER.
ES2306595B1 (en) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. NAPADISYLATE SALT OF 5- (2 - ((6- (2,2-DIFLUORO-2-PHENYLETOXI) HEXIL) AMINO) -1-HYDROXYETHYL) -8-HYDROXYCHINOLIN-2 (1H) -ONE AS ADRENERGIC RECEIVER AGONIST BETA2 .
ES2320955B1 (en) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. NEW DERIVATIVES OF 3 - ((1,2,4) TRIAZOLO (4,3-A) PIRIDIN-7-IL) BENZAMIDA.
ES2320961B1 (en) 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) PHENOL AS BETA2 ADRENERGIC RECEIVER AGONISTS.
EP2096105A1 (en) 2008-02-28 2009-09-02 Laboratorios Almirall, S.A. Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
UY32297A (en) 2008-12-22 2010-05-31 Almirall Sa MESILATE SALT OF 5- (2 - {[6- (2,2-DIFLUORO-2-PHENYLITOXI) HEXIL] AMINO} -1-HYDROXYETHYL) -8-HYDROXYCHINOLIN-2 (1H) -ONA AS A RECEIVER AGONIST B (BETA ) 2 ACRENERGIC
EP2221055A1 (en) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
EP2221297A1 (en) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2228368A1 (en) 2009-03-12 2010-09-15 Almirall, S.A. Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
EP2322176A1 (en) 2009-11-11 2011-05-18 Almirall, S.A. New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
EP2463289A1 (en) 2010-11-26 2012-06-13 Almirall, S.A. Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2518070A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Pyrrolotriazinone derivatives as PI3K inhibitors
EP2518071A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Imidazopyridine derivatives as PI3K inhibitors
EP2526945A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. New CRTH2 Antagonists
EP2527344A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
EP2548863A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists.
EP2548876A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists
EP2554544A1 (en) 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2592077A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP2647627A1 (en) 2012-04-02 2013-10-09 Almirall, S.A. Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
EP2666465A1 (en) 2012-05-25 2013-11-27 Almirall, S.A. Novel dosage and formulation
EP2668941A1 (en) 2012-05-31 2013-12-04 Almirall, S.A. Novel dosage form and formulation of abediterol
WO2014060431A1 (en) 2012-10-16 2014-04-24 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
AU2013360866A1 (en) 2012-12-18 2015-07-02 Almirall, S.A. New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activity
UY35332A (en) 2013-02-15 2014-11-28 Almirall Sa PIRROLOTRIAZINE DERIVATIVES AS PI3K INHIBITORS
EP2848615A1 (en) 2013-07-03 2015-03-18 Almirall, S.A. New pyrazole derivatives as CRAC channel modulators
WO2015091287A1 (en) 2013-12-19 2015-06-25 Almirall S.A. Dosage formulation comprising salmeterol and fluticasone propionate
US10214509B2 (en) 2015-04-21 2019-02-26 Almirall, S.A. Amino-substituted heterocyclic derivatives as sodium channel inhibitors
EP3294390B1 (en) 2015-05-08 2022-10-05 Iconovo AB Dry powder inhaler
WO2016202800A1 (en) 2015-06-16 2016-12-22 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
WO2017076990A1 (en) 2015-11-05 2017-05-11 Almirall, S.A. Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide
TW201919682A (en) 2017-08-08 2019-06-01 西班牙商阿爾米雷爾有限公司 Novel compounds activating the Nrf2 pathway
WO2019066702A1 (en) 2017-09-28 2019-04-04 Iconovo Ab A dry powder inhaler with means for enhancing dispersion

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524769A (en) * 1981-07-08 1985-06-25 Aktiebolaget Draco Dosage inhalator
EP0520440A1 (en) * 1991-06-26 1992-12-30 Schering Corporation Inhalation device for powdered medicaments
WO1993000123A1 (en) * 1991-06-26 1993-01-07 Schering Corporation Inhalation device for powdered medicaments
EP0547429A1 (en) * 1991-12-14 1993-06-23 ASTA Medica Aktiengesellschaft Powder inhaler
WO2003000325A1 (en) 2001-06-22 2003-01-03 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers

Also Published As

Publication number Publication date
ES248348U (en) 1980-05-01
GB2041763A (en) 1980-09-17
GB2041763B (en) 1983-08-17
IT7920688V0 (en) 1979-02-05
DE8002702U1 (en) 1980-05-29
ES248348Y (en) 1981-02-16
IT7920688U1 (en) 1980-08-05
FR2447725B3 (en) 1981-01-02

Similar Documents

Publication Publication Date Title
FR2447725A3 (en) INHALER OF POWDERY DRUG SUBSTANCES, COMBINING THE FUNCTION OF DOSER
ES480164A1 (en) Process for the manufacture of pharmaceutical preparations.
ES421237A1 (en) Apparatus and process for forming contoured impressions of the human body
NL176230C (en) INHALER FOR POWDER SUBSTANCES.
BE900950A (en) DOSAGE FORMS FOR CAPSULES.
AU518563B2 (en) Flow metering for fluid infusion
DK0707862T3 (en) Device for inhalation of powdered substances
BR9507731A (en) Improvement in and referring to particulate material
GB1050559A (en)
PH11643A (en) Dispensing lung contacting powdered medicaments
GB1495805A (en) Device for dispensing a liquid or a powder from a container
FR2506514A1 (en) IMPROVED SUPPORT FOR ABSORBER DEVICES CALLED TO GETTERS
JPS5359176A (en) Sealed type liquid reservoir
PT96962A (en) DEVICE FOR THE INHALATION OF MEDICINES
FR2465902B1 (en) MEMBRANE PUMP FOR DOSING THE TWO COMPONENTS OF A MIXTURE AND PUMP ASSEMBLY COMPRISING TWO PUMPS
FR2396635A1 (en) HORIZONTAL MIXER FOR THERMOPLASTIC MATERIALS
GB1511107A (en) Measuring and dispensing device
CA1024377A (en) Liquid flow meter, rotary positive displacement type
FR2671052B1 (en) IMPROVEMENTS ON BAGS, PARTICULARLY BAGS CONTAINING A DOSE OF ACTIVE PRODUCT, PARTICULARLY IN THE LIQUID, PASTY OR POWDER FORM.
USD245487S (en) Cylindrical flow meter
JPS5318260A (en) Discharge device
GB1485008A (en) Rotatable member for use with a machine for distributing granular materials
BE855848A (en) SEALING ARRANGEMENT FOR PRESSURE HOUSING EQUIPPED WITH A COVER, IN PARTICULAR FOR TAPS HOUSING
Theberge et al. Gear and bearing designs with lubricated and reinforced thermoplastics
JPS5215792A (en) Continous filling cylindrical bag-manufacturing apparatus